DUMAN, S. Et Al. 2023. A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.. AASLD-TASL hepatology connect meeting .

DUMAN, S., KURU ÖZ, D., GÜMÜŞSOY, M., KİREMİTCİ, S., GÖKCAN, H., ÖZERCAN, A. M., ... İDİLMAN, R.(2023). A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone. . AASLD-TASL hepatology connect meeting

DUMAN, SERKAN Et Al. "A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.," AASLD-TASL hepatology connect meeting, 2023

DUMAN, SERKAN Et Al. "A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.." AASLD-TASL hepatology connect meeting , 2023

DUMAN, S. Et Al. (2023) . "A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.." AASLD-TASL hepatology connect meeting .

@conferencepaper{conferencepaper, author={SERKAN DUMAN Et Al. }, title={A combination of non-invasive tests for the detection of significant fibrosis in patients with metabolic dysfunction-associated steatotic liver disease is not superior to magnetic resonance elastography alone.}, congress name={AASLD-TASL hepatology connect meeting}, city={}, country={}, year={2023}}